Gene · 6358
Papers2,754
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
841 to 860 of 2,754
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| In silico approach for the development of novel antiviral compounds based on SARS-COV-2 protease inhibition. | Chem Zvesti | 2022 | 35400796 | PubTator, text mining | PubMed |
| Targeting Chemokine Receptor CCR1 as a Potential Therapeutic Approach for Multiple Myeloma. | Front Endocrinol (Lausanne) | 2022 | 35399952 | PubTator, text mining | PubMed |
| Distinct Immune Gene Programs Associated with Host Tumor Immunity, Neoadjuvant Chemotherapy, and Chemoimmunotherapy in Resectable NSCLC. | Clin Cancer Res | 2022 | 35394499 | PubTator, text mining | PubMed |
| PET imaging of TSPO expression in immune cells can assess organ-level pathophysiology in high-consequence viral infections. | Proc Natl Acad Sci U S A | 2022 | 35385353 | PubTator, text mining | PubMed |
| Astroglial and oligodendroglial markers in the cuprizone animal model for de- and remyelination. | Histochem Cell Biol | 2022 | 35380252 | PubTator, text mining | PubMed |
| Antibodies as biomarkers for cancer risk: a systematic review. | Clin Exp Immunol | 2022 | 35380164 | PubTator, text mining | PubMed |
| Plasma proteome profiling combined with clinical and genetic features reveals the pathophysiological characteristics of β-thalassemia. | iScience | 2022 | 35378860 | PubTator, text mining | PubMed |
| CXCR2 signaling might have a tumor-suppressive role in patients with cholangiocarcinoma. | PLoS One | 2022 | 35377900 | PubTator, text mining | PubMed |
| Bioinformatics and Experimental Analysis of the Prognostic and Predictive Value of the CHPF Gene on Breast Cancer. | Front Oncol | 2022 | 35372047 | PubTator, text mining | PubMed |
| CEMIP as a potential biomarker and therapeutic target for breast cancer patients. | Int J Med Sci | 2022 | 35370456 | PubTator, text mining | PubMed |
| Activities and Molecular Mechanisms of Diterpenes, Diterpenoids, and Their Derivatives in Rheumatoid Arthritis. | Evid Based Complement Alternat Med | 2022 | 35368757 | PubTator, text mining | PubMed |
| Molecular alterations in the integrated diagnosis of pediatric glial and glioneuronal tumors: A single center experience. | PLoS One | 2022 | 35363819 | PubTator, text mining | PubMed |
| Upregulation of Yin-Yang-1 Associates with Proliferation and Glutamine Metabolism in Esophageal Carcinoma. | Int J Genomics | 2022 | 35359580 | PubTator, text mining | PubMed |
| A Pan-Cancer Bioinformatic Analysis of RAD51 Regarding the Values for Diagnosis, Prognosis, and Therapeutic Prediction. | Front Oncol | 2022 | 35359409 | PubTator, text mining | PubMed |
| Clinical monitored in subjects metabolically healthy and unhealthy before and during a SARS-CoV-2 infection- A cross-sectional study in Mexican population. | Cytokine | 2022 | 35358903 | PubTator, text mining | PubMed |
| Genotypic Characterization and Biofilm Production of Group B Streptococcus Strains Isolated from Bone and Joint Infections. | Microbiol Spectr | 2022 | 35357222 | PubTator, text mining | PubMed |
| The surprising effects of sulfur: achieving long excited-state lifetimes in heteroleptic copper(i) emitters. | J Mater Chem C Mater | 2022 | 35340713 | PubTator, text mining | PubMed |
| Deciphering the Role of Protein Phosphatases in Apicomplexa: The Future of Innovative Therapeutics? | Microorganisms | 2022 | 35336160 | PubTator, text mining | PubMed |
| Beyond CC398: Characterisation of Other Tetracycline and Methicillin-Resistant Staphylococcus aureus Genetic Lineages Circulating in Spanish Hospitals. | Pathogens | 2022 | 35335631 | PubTator, text mining | PubMed |
| Acute Kidney Injury: Biomarker-Guided Diagnosis and Management. | Medicina (Kaunas) | 2022 | 35334515 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6358/papers?page=43